Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma

被引:5
|
作者
Zhao, Tiesuo [1 ,2 ,3 ]
Wei, Pengkun [1 ,2 ,4 ]
Zhang, Congli [1 ,2 ]
Zhou, Shijie [1 ,2 ]
Liang, Lirui [1 ,2 ]
Guo, Shuoshuo [1 ,2 ]
Yin, Zhinan [5 ]
Cheng, Sichang [1 ,2 ]
Gan, Zerui [1 ,2 ]
Xia, Yuanling [1 ,2 ]
Zhang, Yongxi [6 ]
Guo, Sheng [1 ,2 ]
Zhong, Jiateng [2 ]
Yang, Zishan [1 ,2 ]
Tu, Fei [2 ]
Wang, Qianqing [7 ,8 ]
Bai, Jin [7 ,8 ]
Ren, Feng [3 ]
Feng, Zhiwei [1 ,2 ]
Jia, Huijie [2 ]
机构
[1] Xinxiang Med Univ, Sch Basic Med Sci, Dept Immunol, Xinxiang, Peoples R China
[2] Xinxiang Med Univ, Xinxiang Engn Technol Res Ctr Immune Checkpoint Dr, Xinxiang, Peoples R China
[3] Xinxiang Med Univ, Henan Int Joint Lab Immun & Targeted Therapy Liver, Xinxiang, Peoples R China
[4] Zhengzhou Univ, Zhengzhou Cent Hosp, Zhengzhou, Peoples R China
[5] Jinan Univ, Biomed Translat Res Inst, Fac Med Sci, Guangzhou, Peoples R China
[6] Xinxiang Med Univ, Affiliated Hosp 3, Dept Oncol, Xinxiang, Peoples R China
[7] Xinxiang Cent Hosp, Dept Gynecol, Xinxiang, Peoples R China
[8] Xinxiang Med Univ, Clin Coll 4, Xinxiang, Peoples R China
来源
ELIFE | 2024年 / 12卷
关键词
hepatocellular carcinoma; PD-L1; radiotherapy; cancer immunotherapy; Mouse;
D O I
10.7554/eLife.90911
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Previous studies have demonstrated that nifuroxazide exerts antitumor activity by damaging the Stat3 pathway, but its efficacy against PD-L1 has remained unclear. In this study, we investigated whether nifuroxazide could enhance the efficacy of radiotherapy in HCC by reducing PD-L1 expression. Our results showed that nifuroxazide significantly increased the sensitivity of tumor cells to radiation therapy by inhibiting cell proliferation and migration while increasing apoptosis in vitro. Additionally, nifuroxazide attenuated the up-regulation of PD-L1 expression induced by irradiation, which may be associated with increased degradation of PD-L1 through the ubiquitination-proteasome pathway. Furthermore, nifuroxazide greatly enhanced the efficacy of radiation therapy in H22-bearing mice by inhibiting tumor growth, improving survival, boosting the activation of T lymphocytes, and decelerating the ratios of Treg cells in spleens. Importantly, nifuroxazide limited the increased expression of PD-L1 in tumor tissues induced by radiation therapy. This study confirms, for the first time, that nifuroxazide can augment PD-L1 degradation to improve the efficacy of radiation therapy in HCC-bearing mice.
引用
收藏
页数:22
相关论文
共 50 条
  • [22] Significance of PD-L1 clones and C-MET expression in hepatocellular carcinoma
    Chun, Hyung-Wook
    Hong, Ran
    ONCOLOGY LETTERS, 2019, 17 (06) : 5487 - 5498
  • [23] EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
    Xiao, Gang
    Jin, Li-Lian
    Liu, Chao-Qun
    Wang, Yong-Chun
    Meng, Ya-Ming
    Zhou, Zhong-Guo
    Chen, Jing
    Yu, Xing-Juan
    Zhang, Yao-Jun
    Xu, Jing
    Zheng, Limin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [24] Mild hyperthermia upregulates PD-L1 in the tumor microenvironment and enhances antitumor efficacy of PD-L1 blockade in murine squamous cell carcinoma
    Ohta, Yuya
    Ichimura, Norihisa
    Yamaguchi, Satoshi
    Ohara, Go
    Yamamoto, Noriyuki
    Itoh, Yoshiyuki
    Yamada, Keiichiro
    Nakamura, Seiji
    Hibi, Hideharu
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2024, 86 (03): : 497 - 506
  • [25] Prognostic Value of PD-L1 in Patients with Hepatocellular Carcinoma
    Pei, Renguang
    Zhang, Weixuan
    Wang, Sufen
    Huang, Xi
    Zou, Yinghua
    CLINICAL LABORATORY, 2019, 65 (05) : 693 - 698
  • [26] Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma
    Luo, Cheng-Piao
    Mo, Han-Yue
    Wu, Ling-Ling
    Ma, Yun
    Peng, Ning-Fu
    EUROPEAN JOURNAL OF CANCER, 2017, 71 : 117 - 118
  • [27] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [28] EXPRESSION AND PREDICTIVE VALUE OF EFFICACY OF PD-1 AND PD-L1 IN LUNG CANCER PATIENTS AFTER RADIOTHERAPY
    DuAN, ZHiHui
    ACTA MEDICA MEDITERRANEA, 2023, 39 (01): : 291 - 298
  • [29] LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression
    Xinling Cao
    Guanping Zhang
    Tao Li
    Chengming Zhou
    Lei Bai
    Jinming Zhao
    Turgunjan Tursun
    Genes & Genomics, 2020, 42 : 1361 - 1368
  • [30] LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression
    Cao, Xinling
    Zhang, Guanping
    Li, Tao
    Zhou, Chengming
    Bai, Lei
    Zhao, Jinming
    Tursun, Turgunjan
    GENES & GENOMICS, 2020, 42 (11) : 1361 - 1368